The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a potential development. Unlike injections, this method offers a less invasive way to provide GLP-1 drugs. These https://rebeccacbfa171101.loginblogin.com/49129324/glp-1-patches-a-innovative-approach-to-glucose-control